Skip to main content

Cell therapy pioneer Dr. Carl June to chair Chinese biotech firm's scientific advisory board

June led the team at Penn that developed the first FDA-approved CAR-T cell therapy to treat acute lymphoblastic leukemia.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.